Cite
Plasma DNA Integrity as a Prognostic Biomarker for Colorectal Cancer Chemotherapy
MLA
Jiangman Zhao, et al. “Plasma DNA Integrity as a Prognostic Biomarker for Colorectal Cancer Chemotherapy.” Journal of Oncology, vol. 2021, May 2021, pp. 1–10. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c10d0432234cdda4fb0c8adee57be6aa&authtype=sso&custid=ns315887.
APA
Jiangman Zhao, Huiyuan Li, Dongdong Ru, Feng Zhu, Jianfeng Li, Ningning Wu, Jing Ma, Yunhua Zhang, Huiling Zhang, Yusheng Wang, Hui Tang, Weihua Fu, Yue Xu, & Xiaoli Liu. (2021). Plasma DNA Integrity as a Prognostic Biomarker for Colorectal Cancer Chemotherapy. Journal of Oncology, 2021, 1–10.
Chicago
Jiangman Zhao, Huiyuan Li, Dongdong Ru, Feng Zhu, Jianfeng Li, Ningning Wu, Jing Ma, et al. 2021. “Plasma DNA Integrity as a Prognostic Biomarker for Colorectal Cancer Chemotherapy.” Journal of Oncology 2021 (May): 1–10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c10d0432234cdda4fb0c8adee57be6aa&authtype=sso&custid=ns315887.